These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33968042)

  • 1. Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris.
    Huang Y; Jedličková H; Cai Y; Rehman A; Gammon L; Ahmad US; Uttagomol J; Parkinson EK; Fortune F; Wan H
    Front Immunol; 2021; 12():649502. PubMed ID: 33968042
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris.
    Alabeedi FMA
    Autoimmunity; 2024 Dec; 57(1):2377138. PubMed ID: 39037929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 4. ST18 Enhances PV-IgG-Induced Loss of Keratinocyte Cohesion in Parallel to Increased ERK Activation.
    Radeva MY; Walter E; Stach RA; Yazdi AS; Schlegel N; Sarig O; Sprecher E; Waschke J
    Front Immunol; 2019; 10():770. PubMed ID: 31057535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
    Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
    Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53.
    Rehman A; Cai Y; Hünefeld C; Jedličková H; Huang Y; Teck Teh M; Sharif Ahmad U; Uttagomol J; Wang Y; Kang A; Warnes G; Harwood C; Bergamaschi D; Kenneth Parkinson E; Röcken M; Wan H
    Cell Death Dis; 2019 Oct; 10(10):750. PubMed ID: 31582719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris.
    Kugelmann D; Anders M; Sigmund AM; Egu DT; Eichkorn RA; Yazdi AS; Sárdy M; Hertl M; Didona D; Hashimoto T; Waschke J
    Front Immunol; 2022; 13():884248. PubMed ID: 35844545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dsg2 Upregulation as a Rescue Mechanism in Pemphigus.
    Sigmund AM; Steinert LS; Egu DT; Bayerbach FC; Waschke J; Vielmuth F
    Front Immunol; 2020; 11():581370. PubMed ID: 33193387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.
    Uttagomol J; Ahmad US; Rehman A; Huang Y; Laly AC; Kang A; Soetaert J; Chance R; Teh MT; Connelly JT; Wan H
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
    Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
    Front Immunol; 2019; 10():1128. PubMed ID: 31178865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
    Hébert V; Novarino J; Maho-Vaillant M; Perals C; Calbo S; Golinski ML; Martinez F; Joly P; Fazilleau N
    Br J Dermatol; 2024 Sep; 191(4):605-615. PubMed ID: 38848544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Src and Cortactin in Pemphigus Skin Blistering.
    Kugelmann D; Rötzer V; Walter E; Egu DT; Fuchs MT; Vielmuth F; Vargas-Robles H; Schnoor M; Hertl M; Eming R; Rottner K; Schmidt A; Spindler V; Waschke J
    Front Immunol; 2019; 10():626. PubMed ID: 31024527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
    Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
    J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.